SYSTEMIC SCLEROSIS-ASSOCIATED PRECAPILLARY PULMONARY HYPERTENSION WITH AND WITHOUT INTERSTITIAL LUNG DISEASE: OBSERVATIONS FROM A SINGLE REFERRAL CENTER COHORT

被引：1
|
作者：
Ahmad, Yousef
Zhou, Christine
Olmstead, Keegan
Khan, Sarah
Windholz, Julie
Gupta, Nishant
Gomez-Arroyo, Jose
Elwing, Jean
机构：
来源：
CHEST | 2020年 / 158卷 / 04期
关键词：
D O I：
10.1016/j.chest.2020.08.991
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1076A / 1077A
页数：2
相关论文
共 50 条
  • [31] Nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease
    Yamasaki, Yoshioki
    Kuwana, Masataka
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (06) : 547 - 560
  • [32] Systemic sclerosis-associated interstitial lung disease treated with tocilizumab
    Dauny, Vincent
    Borie, Raphael
    Forien, Marine
    Ghanem, Mada
    Palazzo, Elisabeth
    Jelin, Germain
    Dieude, Philippe
    Ottaviani, Sebastien
    INTERNAL MEDICINE JOURNAL, 2021, 51 (06) : 999 - 1000
  • [33] Pleuroparenchymal fibroelastosis in systemic sclerosis-associated interstitial lung disease
    Sari, Alper
    Onder, Omer
    Armagan, Berkan
    Bolek, Ertugrul Cagri
    Farisogullari, Bayram
    Bilgin, Emre
    Yardimci, Gozde Kubra
    Ariyurek, Macit
    Akdogan, Ali
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2022, 52 (01) : 83 - 88
  • [34] Molecular Insights Into Systemic Sclerosis-Associated Interstitial Lung Disease
    Silver, Richard M.
    Feghali-Bostwick, Carol A.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 (03) : 485 - 487
  • [35] Current treatment of systemic sclerosis-associated interstitial lung disease
    Bes, Cemal
    Cetinkaya, Erdogan
    TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, 2022, 70 (01): : 85 - 92
  • [36] Changes In Hemodynamic Classification Over Time In Systemic Sclerosis-Associated Pulmonary Hypertension: Observations From The Pharos Cohort
    Lammi, M. R.
    Saketkoo, L.
    Gordon, J.
    Steen, V.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [37] Risk factors for lung function decline in systemic sclerosis-associated interstitial lung disease in a large single-centre cohort
    Ramahi, Ahmad
    Lescoat, Alain
    Roofeh, David
    Nagaraja, Vivek
    Namas, Rajaie
    Huang, Suiyuan
    Varga, John
    O'Dwyer, David
    Wang, Bonnie
    Flaherty, Kevin
    Kazerooni, Ella
    Khanna, Dinesh
    RHEUMATOLOGY, 2023, 62 (07) : 2501 - 2509
  • [38] Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progression
    Stock, Carmel J. W.
    Hoyles, Rachel K.
    Daccord, Cecile
    Kokosi, Maria
    Visca, Dina
    De Lauretis, Angelo
    Alfieri, Veronica
    Kouranos, Vasilis
    Margaritopoulos, George
    George, Peter M.
    Molyneaux, Philip L.
    Chua, Felix
    Maher, Toby M.
    Abraham, David J.
    Ong, Voon
    Donovan, Jackie
    Sestini, Piersante
    Denton, Christopher P.
    Wells, Athol U.
    Renzoni, Elisabetta A.
    RESPIROLOGY, 2021, 26 (05) : 461 - 468
  • [39] Incidence and prevalence of Systemic Sclerosis-associated Interstitial Lung Disease in a multicenter prospective cohort study
    Vandecasteele, Els
    Melsens, Karin
    Blockmans, Daniel
    Carton, Charlotte
    De Keyser, Filip
    De Langhe, Ellen
    Lauwerys, Bernard
    Piette, Yves
    Vanhaecke, Amber
    Verbeke, Koen
    Wuyts, Wim
    Brusselle, Guy
    Smith, Vanessa
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [40] RELATIONSHIP BETWEEN RADIOLOGICAL VASCULAR PRUNING AND INTERSTITIAL LUNG ABNORMALITIES IN SYSTEMIC SCLEROSIS PATIENTS WITH AND WITHOUT PRECAPILLARY PULMONARY HYPERTENSION
    Petersen, Lauren
    Zhou, Christine Y.
    Gupta, Nishant
    Elwing, Jean M.
    Amin, Raouf
    Madala, Satish
    Busald, Tina
    Gomez-Arroyo, Jose G.
    CHEST, 2024, 166 (04) : 3307A - 3309A
12345